TechTalkXL: Cell & Gene Therapy – 30 June 2026 | NecstGen

NecstGen hosts TechTalkXL: Cell & Gene Therapy on 30 June 2026 in Leiden, as part of Dutch Bio Science Week. Join expert speakers and the CGT community for an afternoon of focused exchange. Free to attend, registration required.

Which ideas, technologies, and perspectives are currently moving Cell and Gene Therapy forward? On Tuesday, 30 June 2026, NecstGen will host TechTalkXL: Cell & Gene Therapy in Leiden, as part of Dutch Bio Science Week, organised by Leiden Bio Science Park. The event brings together professionals working in or closely following the field of Cell and Gene Therapy for an afternoon of expert presentations, snapshot talks, and peer exchange.

About the Event

Cell and Gene Therapy is advancing across a range of areas, including oncology, rare genetic disorders, and degenerative diseases. Progress in clinical translation, process development, and enabling technologies is shaping what becomes possible and what the next steps look like in practice.

TechTalkXL provides a setting to examine these developments directly, with speakers actively involved in bringing therapies forward. The format is focused and practical: expert presentations followed by shorter snapshot talks and dedicated time to connect with colleagues and peers from across the field.

Programme


15:30 – Arrival & Registration
16:00 – Speaker Session 
17:15 – Snapshot Talks
From 17:30 – Networking

Speakers


There will be an exciting speaker program, including the following experts from the field: 

Snapshot Talks

  • An end-to-end RNA platform – from IVT to formulation – empowering faster, simpler, and scalable therapies production
    • Yuliya Shakalisava, EXIT071
  • Beyond the Cell: Harnessing Exosomes for Diagnostics and Therapeutics
    • Emilie Viey, Quantoom Biosciences

Practical Information

Date: Tuesday, 30 June 2026 Location: Leiden, The Netherlands, Leiden Bio Science Park Participation: Free of charge Registration: Required

TechTalkXL is open to anyone working in or engaged with the field of Cell and Gene Therapy. If this is relevant for you or your team, we invite you to save the date and register via the link below.

Register Now


Events like these are part of NecstGen’s ongoing effort to strengthen collaboration and knowledge exchange across the Cell and Gene Therapy development chain. We look forward to welcoming you in Leiden.




The First Stages of CAR T Cell Therapy Development

The First Stages of CAR T Cell Therapy Development

Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment by harnessing a patient's immune system to target and eliminate (cancer) cells. These novel therapies...

Webinar LV Process for CAR T

Webinar LV Process for CAR T

Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.

Ready to discuss your GMP path?

Our experts are only a message away to help you understand the impact of any choices and to inform decision-making.

We’d be happy to discuss and help you bring Cell and Gene Therapies to patients.

NecstGen Services

Cell Therapy Development & Manufacturing

Viral Vector Development & Manufacturing

Cleanroom Rental

Consultancy

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.

About Us

Partners

History

Facility

Ecosystem